WHO alert on Indian firm linked to exports of ‘unsafe’ syrups in Iraq
HQ Team August 7, 2023: The WHO issued a medical product alert, the fifth such on an Indian company’s syrup, terming it “substandard,”.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team August 7, 2023: The WHO issued a medical product alert, the fifth such on an Indian company’s syrup, terming it “substandard,”.
HQ Team August 1, 2023: India has ordered a shutdown of a domestic pharmaceutical firm, whose cough syrup is believed to be behind.
HQ Team July 20, 2023: The WHO has sounded a global alert on a batch of substandard cough syrup found in Cameroon, which.
A probe by the US-based Centres for Disease Control into the deaths of 70 children in Gambia "strongly suggests" cough syrups involving contaminated.
The WHO called on stakeholders in various nations to take “immediate and coordinated action” to shield children from using contaminated cough syrups following.
Samples of Indian cough syrups, linked to the deaths of 66 children in Gambia, complied with government specifications and were not contaminated.
Indian drugmaker Maiden Pharma linked to 66 deaths in Gambia